- Prefilled syringe offers healthcare professionals a convenient administration option
- New presentation will begin rolling out across EU countries in 2026
- Shingles affects approximately 1.7 million people in Europe each year,1 with certain chronic…
GSK’s Shingrix (Recombinant Zoster Vaccine) prefilled syringe presentation approved by the European Commission
